Article
APEX1 Polymorphism and Mercaptopurine-Related Early Onset Neutropenia in Pediatric Acute Lymphoblastic Leukemia.
Cancer research and treatment - 1 Jul 2018
Kim Hyery, Seo Heewon, Park Yoomi, Min Byung-Joo, Seo Myung-Eui, Park Kyung Duk, Shin Hee Young, Kim Ju Han, Kang Hyoung Jin
Abstract excerpt
PURPOSE: Mercaptopurine (MP) is one of the main chemotherapeutics for acute lymphoblastic leukemia (ALL). To improve treatment outcomes, constant MP dose titration is essential to maintain steady drug exposure, while minimizing myelosuppression. We performed two-stage analyses to identify genetic determinants of MP-related neutropenia in Korean pediatric ALL patients. MATERIALS AND METHODS: Targeted sequencing of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
